1. Home
  2. QURE vs EIG Comparison

QURE vs EIG Comparison

Compare QURE & EIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • EIG
  • Stock Information
  • Founded
  • QURE 1998
  • EIG 2000
  • Country
  • QURE Netherlands
  • EIG United States
  • Employees
  • QURE N/A
  • EIG N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • EIG Property-Casualty Insurers
  • Sector
  • QURE Health Care
  • EIG Finance
  • Exchange
  • QURE Nasdaq
  • EIG Nasdaq
  • Market Cap
  • QURE 866.3M
  • EIG 1.0B
  • IPO Year
  • QURE 2007
  • EIG 2007
  • Fundamental
  • Price
  • QURE $17.10
  • EIG $42.35
  • Analyst Decision
  • QURE Strong Buy
  • EIG Strong Buy
  • Analyst Count
  • QURE 11
  • EIG 1
  • Target Price
  • QURE $39.91
  • EIG $58.00
  • AVG Volume (30 Days)
  • QURE 966.4K
  • EIG 161.1K
  • Earning Date
  • QURE 11-04-2025
  • EIG 10-29-2025
  • Dividend Yield
  • QURE N/A
  • EIG 3.04%
  • EPS Growth
  • QURE N/A
  • EIG N/A
  • EPS
  • QURE N/A
  • EIG 4.10
  • Revenue
  • QURE $14,337,000.00
  • EIG $889,500,000.00
  • Revenue This Year
  • QURE N/A
  • EIG $0.86
  • Revenue Next Year
  • QURE $301.10
  • EIG $0.80
  • P/E Ratio
  • QURE N/A
  • EIG $10.27
  • Revenue Growth
  • QURE N/A
  • EIG 2.32
  • 52 Week Low
  • QURE $4.45
  • EIG $38.19
  • 52 Week High
  • QURE $19.18
  • EIG $54.44
  • Technical
  • Relative Strength Index (RSI)
  • QURE 60.57
  • EIG 45.92
  • Support Level
  • QURE $16.69
  • EIG $41.62
  • Resistance Level
  • QURE $17.76
  • EIG $43.53
  • Average True Range (ATR)
  • QURE 0.77
  • EIG 0.64
  • MACD
  • QURE 0.01
  • EIG 0.01
  • Stochastic Oscillator
  • QURE 62.76
  • EIG 30.67

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

Share on Social Networks: